NYSEMKT:DXR
Daxor Corp Stock News
$8.57
-0.0550 (-0.638%)
At Close: Mar 27, 2024
Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference
09:15am, Thursday, 07'th Sep 2023
Oak Ridge, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh w
Daxor Corporation (DXR) Q4 2022 Earnings Call Transcript
03:04pm, Monday, 06'th Mar 2023
Daxor Corporation (NASDAQ:DXR ) Q4 2022 Results Conference Call March 2, 2023 9:00 AM ET Company Participants Scott Gordon - President, Core IR Michael Feldschuh - CEO Robert Michel - CFO Conference C
Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option
04:07pm, Thursday, 17'th Nov 2022 GlobeNewswire Inc.
Oak Ridge, TN, Nov. 17, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the c
Dow Surges More Than 300 Points After Producer Prices Increase Less Than Expected
03:12pm, Tuesday, 15'th Nov 2022 Benzinga
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Tuesday.
Following the market opening Tuesday, the Dow traded up 0.91% to 33,841.32 while the NASDAQ rose 2.0
Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering
01:45pm, Tuesday, 15'th Nov 2022 GlobeNewswire Inc.
Oak Ridge, TN, Nov. 15, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the p
Daxor Corporation Announces Launch of Proposed Underwritten Public Offering
10:03pm, Monday, 14'th Nov 2022 GlobeNewswire Inc.
Oak Ridge, TN, Nov. 14, 2022 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced that
New Data Shows 85% Reduction In One-Year Mortality For Medicare Heart Failure Patients With BVA-Guided Care
12:40pm, Monday, 03'rd Oct 2022 GlobeNewswire Inc.
Patient One-Year Mortality Rate 5.6% with BVA-Guided Care Compared to 36.8% in Control Group - Data Presented at Key Scientific Meeting
Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference
09:05pm, Tuesday, 06'th Sep 2022 GlobeNewswire Inc.
Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh
Daxor Corporation to Attend the H.C. Wainwright 24th Annual Global Investment Conference
05:05pm, Tuesday, 06'th Sep 2022
Oak Ridge, TN, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh wi
Daxor Corporation (DXR) Q2 2022 Earnings Call Transcript
07:06pm, Friday, 26'th Aug 2022
Daxor Corporation (NASDAQ:DXR ) Q2 2022 Earnings Conference Call August 25, 2022 4:30 PM ET Company Participants Scott Gordon - President and Co-Founder of CORE IR Michael Feldschuh - CEO & President
Daxor Corporation Reports a 92.6 Percent Revenue Increase in Diagnostic Operating Division in Form N-CSR Filing for the Six Months Ended June 30, 2022
08:05pm, Thursday, 25'th Aug 2022 GlobeNewswire Inc.
Conference Call to be held today at 4:30 p.m. Eastern Time
Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update
08:40pm, Wednesday, 24'th Aug 2022 GlobeNewswire Inc.
Conference Call to be held on the same day at 4:30 p.m. Eastern Time
Daxor Corporation to Report First Half 2022 Financial Results on Thursday, August 25, 2022, and Provide Corporate Update
04:40pm, Wednesday, 24'th Aug 2022
Conference Call to be held on the same day at 4:30 p.m. Eastern Time
Daxor Corporation to Present at the H.C. Wainwright & Company Global Investment Conference
08:00am, Thursday, 12'th May 2022
NEW YORK, May 12, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that President and CEO Michael Feldschuh will pres
Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
12:00pm, Wednesday, 23'rd Mar 2022 GlobeNewswire Inc.
Oak Ridge, TN, March 23, 2022 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces that President and CEO Michael Feldschuh will p